$0.0664
al cierre: Oct 14, 3:16 PM EDT
Petros Pharma informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Petros Pharma utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PTPI | Petros Pharma | -$13.25 | — | — | — | $1.58M | — | — | — | 11/12/2025 | |
PTPI | Petros Pharma | -$9.25 | — | -$3.73 | — | $1.42M | — | $0.00 | — | 08/14/2025 | |
PTPI | Petros Pharma | -$42.25 | — | -$8.46 | — | $1.39M | — | $0.00 | — | 05/15/2025 | |
PTPI | Petros Pharma | -$54.25 | — | -$29.00 | — | $364.25K | — | $725.40K | — | 03/31/2025 | |
PTPI | Petros Pharma | -$57.75 | -$7.25 | -$13.25 | -82.76% | $1.68M | $1.34M | $1.58M | 17.61% | 11/13/2024 | |
PTPI | Petros Pharma | -$30.00 | -$19.25 | -$9.25 | 51.95% | $1.99M | $1.40M | $1.42M | 1.50% | 08/14/2024 | |
PTPI | Petros Pharma | -$165.00 | -$36.00 | -$42.25 | -17.36% | $2.52M | $1.45M | $1.39M | -4.21% | 05/15/2024 | |
PTPI | Petros Pharma | -$50.75 | -$27.75 | -$54.25 | -95.50% | $798.10K | $1.55M | $364.25K | -76.50% | 04/01/2024 | |
PTPI | Petros Pharma | -$167.50 | — | -$57.75 | — | -$1.46M | — | $1.68M | — | 11/15/2023 | |
PTPI | Petros Pharma | -$22.50 | — | -$30.00 | — | $4.19M | — | $1.99M | — | 08/14/2023 | |
PTPI | Petros Pharma | -$2.50 | — | -$165.00 | — | $2.46M | — | $2.52M | — | 05/15/2023 | |
PTPI | Petros Pharma | -$187.50 | — | -$50.75 | — | -$867.16K | — | $798.10K | — | 03/31/2023 | |
PTPI | Petros Pharma | -$42.50 | — | -$167.50 | — | $2.15M | — | -$1.46M | — | 11/15/2022 | |
PTPI | Petros Pharma | -$55.00 | — | -$22.50 | — | $2.46M | — | $4.19M | — | 08/15/2022 | |
PTPI | Petros Pharma | — | — | -$2.50 | — | — | — | $2.46M | — | 05/16/2022 | |
PTPI | Petros Pharma | — | — | -$187.50 | — | — | — | -$867.16K | — | 04/01/2022 | |
PTPI | Petros Pharma | — | — | -$42.50 | — | — | — | $2.15M | — | 11/15/2021 | |
PTPI | Petros Pharma | — | — | -$55.00 | — | — | — | $2.46M | — | 08/16/2021 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-13.25 | $-7.25 | -82.8 % |
Q2 | 2024-08-14 | $-9.25 | $-19.25 | 51.9 % |
Q1 | 2024-05-15 | $-42.25 | $-36.00 | -17.4 % |
Q4 | 2024-04-01 | $-54.25 | $-27.75 | -95.5 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q3 | 2024-11-13 | $1.58M | $1.34M | 17.6 % |
Q2 | 2024-08-14 | $1.42M | $1.40M | 1.50 % |
Q1 | 2024-05-15 | $1.39M | $1.45M | -4.21 % |
Q4 | 2024-04-01 | $364.25K | $1.55M | -76.5 % |
Está previsto que Petros Pharma (PTPI) presente resultados el noviembre 12, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
El BPA real fue de $-3.73, que no alcanzó la estimación de $0.00.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.